Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Dtsch Med Wochenschr ; 134(14): 683-5, 2009 Apr.
Artículo en Alemán | MEDLINE | ID: mdl-19319768

RESUMEN

HISTORY AND CLINICAL FINDINGS: A 45-year-old women presented with muscular weakness, restlessness and blurred vision. She had been taking 25 mg hydrochlorothiazide daily and had ingested 7 liters of herbal tea during the day of admission. INVESTIGATIONS AND CLINICAL FINDINGS: Laboratory data showed severe hyponatremia (108 mmol/l, normal range 136 - 152), reduced potassium, glomerular filtration rate as well as plasma and urine osmolality, while the osmolality of the urine was lower than that of the plasma. Creatine kinase and myoglobin were elevated more than one hundredfold. CT scans of the brain was normal. TREATMENT AND COURSE: The normovolemic hyponatremia had caused encephalopathy and rhabdomyolysis resulting in temporary disorder of renal function. Despite of immediately started infusion of standard sodium solution to elevate the serum sodium level slowly the encephalopathy deteriorated initially, but ultimately recovered completely. CONCLUSION: Patients with severe hyponatremic encephalopathy require an immediate treatment, but the sodium level should not be elevated by more than 10 mmol/l per day, in order to avoid spontaneous pontine myelinolysis. Even when the hyponatremia is carefully corrected, the encephalopathy may deteriorate in the course of treatment.


Asunto(s)
Bebidas/efectos adversos , Encefalopatías/etiología , Diuréticos/efectos adversos , Hidroclorotiazida/efectos adversos , Hiponatremia/etiología , Rabdomiólisis/etiología , Encefalopatías/terapia , Diuréticos/administración & dosificación , Femenino , Humanos , Hidroclorotiazida/administración & dosificación , Hiponatremia/complicaciones , Hiponatremia/terapia , Soluciones Isotónicas , Riñón/fisiopatología , Persona de Mediana Edad , Rabdomiólisis/terapia , Cloruro de Sodio/administración & dosificación , Resultado del Tratamiento
3.
Z Gastroenterol ; 46(12): 1372-5, 2008 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-19053006

RESUMEN

The development of eosinophilic gastritis immediately after Helicobacter pylori eradication has not previously been described: A 62-year-old woman developed eosinophilic gastritis immediately after a triple therapy for Helicobacter pylori eradication, consisting of pantoprazole, amoxicillin and clarithromycin. She suffered from burning epigastric pain and loss of appetite. Blood eosinophilia, gastritis and eosinophilic infiltration of the gastric corpus wall were detected. The treatment with low-dose prednisolone led to remission of the blood eosinophilia, complaints, gastritis and eosinophilic infiltration. The remission persisted after the prednisolone treatment had been finished. Eosinophilic gastritis can be diagnosed only by pathohistological examination. This need for biopsy should be stressed, because the usual gastritis treatment with proton pump inhibitors fails in cases of eosinophilic gastritis. Helicobacter pylori does not seem to play a significant role in the aetiopathology of this disorder. In our case, we suggest that the eradication drug therapy actually caused the disease.


Asunto(s)
2-Piridinilmetilsulfinilbencimidazoles/efectos adversos , Amoxicilina/efectos adversos , Antibacterianos/efectos adversos , Antiulcerosos/efectos adversos , Claritromicina/efectos adversos , Eosinofilia/inducido químicamente , Gastritis/inducido químicamente , Gastritis/tratamiento farmacológico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , 2-Piridinilmetilsulfinilbencimidazoles/uso terapéutico , Amoxicilina/uso terapéutico , Antibacterianos/uso terapéutico , Antiulcerosos/uso terapéutico , Biopsia , Claritromicina/uso terapéutico , Quimioterapia Combinada , Endosonografía , Eosinofilia/patología , Femenino , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/patología , Gastritis/patología , Gastroscopía , Humanos , Persona de Mediana Edad , Pantoprazol
4.
Unfallchirurg ; 108(11): 994-7, 2005 Nov.
Artículo en Alemán | MEDLINE | ID: mdl-15925967

RESUMEN

A 78 year old woman had suffered ten spontaneous bone fractures, the first occurring when she was 57 years old. She is now wheel-chair bound. After 21 years, the underlying osteomalacia due to oligosymptomatic celiac disease with malabsorption was diagnosed. The treatment consists of a gluten free diet and substitution of calcium and vitamin D until there is a normalisation of calcium, vitamin D and alkaline phosphatase. Any spontaneous fracture deserves a careful search for metabolic bone disease. An elevation of alkaline phosphatase indicates osteomalacia rather than osteoporosis.


Asunto(s)
Enfermedad Celíaca/complicaciones , Enfermedad Celíaca/diagnóstico , Fracturas Espontáneas/diagnóstico , Fracturas Espontáneas/etiología , Osteomalacia/complicaciones , Osteomalacia/diagnóstico , Anciano , Enfermedad Celíaca/terapia , Femenino , Humanos , Osteomalacia/terapia
5.
Internist (Berl) ; 45(6): 713-6, 2004 Jun.
Artículo en Alemán | MEDLINE | ID: mdl-15133612

RESUMEN

A 35 year old male suffered from fever till 39 degrees C and malaise since 6 months; infectious or neoplastic causes have been ruled out. Ultrasonography revealed a hypoechoic lesion of 75 mm diameter in the liver. The histologic examination of the needle biopsy showed an inflammatory process, and the final diagnosis was inflammatory pseudotumor. EBV specific LMP-1 protein was detected within the tumor immunohistochemically. A liver segment resection was performed, and the patient has been well and without fever since then for 18 months. Inflammatory pseudotumor is a rare but important differential diagnosis in cases of hypoechoic liver lesions associated by fever, if there is no abscess or malignancy. The diagnosis must be confirmed histologically, because imaging techniques cannot reliably classify the lesion.


Asunto(s)
Proteínas Portadoras/análisis , Fiebre de Origen Desconocido/diagnóstico , Granuloma de Células Plasmáticas/diagnóstico por imagen , Granuloma de Células Plasmáticas/patología , Hepatopatías/diagnóstico por imagen , Hepatopatías/patología , Proteínas Adaptadoras Transductoras de Señales , Adulto , Proteínas del Citoesqueleto , Diagnóstico Diferencial , Fiebre de Origen Desconocido/etiología , Granuloma de Células Plasmáticas/complicaciones , Granuloma de Células Plasmáticas/cirugía , Humanos , Péptidos y Proteínas de Señalización Intracelular , Proteínas con Dominio LIM , Hígado/diagnóstico por imagen , Hígado/patología , Hepatopatías/complicaciones , Hepatopatías/cirugía , Masculino , Ultrasonografía
6.
Med Klin (Munich) ; 92(5): 265-72, 1997 May 15.
Artículo en Alemán | MEDLINE | ID: mdl-9244832

RESUMEN

The treatment of viral hepatitis or malignomas with interferon (IFN) can increase the incidence of autoimmune disease. This paper reviews published case and study reports. The incidence of overt autoimmune diseases under IFN treatment is about 3%. Autoantibodies can be detected in 23% of the patients. Autoimmune thyroid diseases are the most frequent ones, but nearly all autoimmune diseases can occur. Beside benign and reversible courses chronic developments and lethal outcomes are possible. Actual concepts concerning the pathogenesis of IFN-associated autoimmunity include induction of MHC and other molecules as well as the modulation of lymphocyte functions. Clinical and paraclinical controls are necessary under treatment with IFN and during follow-up.


Asunto(s)
Enfermedades Autoinmunes/inducido químicamente , Interferones/efectos adversos , Anemia Hemolítica Autoinmune/inducido químicamente , Enfermedades Autoinmunes/epidemiología , Enfermedades del Colágeno/inducido químicamente , Hepatitis Viral Humana/terapia , Humanos , Incidencia , Interferones/uso terapéutico , Linfocitos/efectos de los fármacos , Complejo Mayor de Histocompatibilidad/efectos de los fármacos , Neoplasias/terapia , Trombocitopenia/inducido químicamente , Tiroiditis Autoinmune/inducido químicamente
7.
Int Arch Allergy Immunol ; 106(2): 169-72, 1995 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-7819747

RESUMEN

The induction of insulin antibodies and the development of an insulin allergy were observed in a male diabetic patient treated with insulin during alpha-IFN therapy of renal cell carcinoma. Diabetes and renal cell carcinoma were diagnosed at the same time. The patient was treated with biosynthetic human insulin and nephrectomy was performed. Four months later, antineoplastic chemotherapy was started (alpha-IFN, vinblastin). Six weeks after initiation of alpha-IFN injections, the patient reported signs of insulin allergy. Significant titers of insulin antibodies of both the IgG and IgE subclasses were found in the serum at that time and during follow-up, but not before the treatment with alpha-IFN. None of the other autoantibodies investigated were positive.


Asunto(s)
Carcinoma de Células Renales/terapia , Diabetes Mellitus/inmunología , Hipersensibilidad a las Drogas/etiología , Anticuerpos Insulínicos/biosíntesis , Insulina/inmunología , Interferón-alfa/efectos adversos , Neoplasias Renales/terapia , Adulto , Diabetes Mellitus/tratamiento farmacológico , Humanos , Interferón alfa-2 , Masculino , Proteínas Recombinantes
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA